Maximum quantity allowed is 999
请选择数量
CAS RN: 1783-84-2 | 產品號碼: E0640
all cis-8,11,14-Eicosatrienoic Acid

* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
補充產品訊息:
Due to the limited filling volume, some of the product may stick to the inner walls of the bottle.
產品規格
Appearance | Colorless to Light yellow to Light orange clear liquid |
Purity(GC) | min. 98.0 % |
NMR | confirm to structure |
性質
沸點 | 200 °C |
flp | 62 °C |
折射率 | 1.48 |
GHS
信號詞 | Warning |
危險性說明 | H227 : Combustible liquid. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P210 : Keep away from heat/sparks/open flames/hot surfaces. No smoking. P280 : Wear protective gloves/ eye protection/ face protection. P370 + P378 : In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish. P403 + P235 : Store in a well-ventilated place. Keep cool. |
相關法規
RTECS # | JX3880000 |
運輸資料
HS編碼* | 2916.19-000 |
Application
all cis-8,11,14-Eicosatrienoic Acid: an ω-6 fatty acid with anti-inflammatory effect
all cis-8,11,14-Eicosatrienoic acid or dihomo-γ-linolenic acid (DGLA) is a 20-carbon ω-6 fatty acid. The eicosanoid metabolites of DGLA have anti-inflammatory effect; in contrast with the eicosanoid metabolites of arachidonic acid (AA) [A0781] have inflammatory mediator effect. In addition to yielding the anti-inflammatory eicosanoids, DGLA competes with AA for cyclooxygenase (COX) and lipoxygenase, inhibiting the production of AA's eicosanoid metabolites.
References
- COX-2 inhibitors and metabolism of essential fatty acids (a review)
- Multiple roles of dihomo-γ-linolenic acid against proliferation diseases (a review)
- The fatty acids and the skin: a focus on the n-6 family of unsaturated fatty acids (a review)
考研文獻
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。